Summary:

Click image to enlargeThis clinical trial is evaluating the safety and effectiveness of an investigational long-acting insulin taken weekly compared to an approved long-acting daily insulin in adults with type 2 diabetes who have never taken insulin before.
Qualified Participants Must:
Be 18 years of age or older
Have a diagnosis of type 2 diabetes
Have taken at least 1 medicine to treat diabetes for the past 3 months
Never been prescribed insulin before
Additional criteria apply
Qualified Participants May Receive:
Up to $1850 compensation for time and effort; Investigational medication or approved medication; Study-related medical supplies, blood tests and medical evaluations under the care of a physician.